Alira Health

Essential Elements of Technology Transfer

The lifecycle of pharmaceutical development always requires the transfer of the production process and analytical methods from development into Good Manufacturing Practices (GMP) manufacturing and quality control laboratories.

This transfer can take many forms. Traditional pharmaceutical organizations usually have full in-house product development and manufacturing capability, whereas small startup organizations leverage contract development and manufacturing organizations (CDMOs) to bring their discoveries from the research bench to human clinical trials.

Regardless of the nature and maturity of the organization, an effective technology transfer program is essential to the success of pharmaceutical development.

Scientific Articles
Category:
Published on:
September 21, 2023
Peter Alexander

Our own Peter Alexander, Senior Consultant, Chemistry, Manufacturing & Controls (CMC), co-authored an article entitled “Essential Elements Of Technology Transfer” that dives into technology transfer categories, essential elements, documentation, and much more.

The article is available on “Bioprocess Online.”

Contact us to discover how our team’s comprehensive knowledge in biologics and ADCs can make a significant difference in your development journey.

Related news

Events February 3, 2025
Technology and Heart Failure Therapeutics Conference 2025
Look for our cardiovascular experts onsite in Boston to discuss your development support needs.
CDMO Medical Devices MedTech
Uncategorized January 23, 2025
The 2025 Global Medtech Contract Manufacturing Report
Discover the trends in the world of medical device CDMOs and their meaning for the industry in 2025 and beyond.
CDMO MedTech
Events January 15, 2025
MD&M West 2025
Join our Coffee Talk session “Private Equity Buy-and-Build Strategies in Medtech CDMO” on Tuesday, February 4 at MD&M West.
CDMO Medical Devices MedTech
Reports December 12, 2024
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
Advanced Therapies Biologics CDMO
Articles October 16, 2024
Biologics and Advanced Therapies Contract Manufacturing Industry: Current Trends, Challenges, and Opportunities
Summary of the 2024 Biologics and Advanced Therapies Contract Manufacturing Report including industry performance and outsourcing trends.
Advanced Therapies Biologics CDMO
Uncategorized October 8, 2024
Critical Quality Attributes for Drug Products Preview
In this article, we explore the importance of Critical Quality Attributes in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Biotech CDMO Drug Development
News September 23, 2024
Alira Health Releases 2024 Biologics and Advanced Therapies CDMO Market Report Amid Continued Macro-Economic Uncertainty
Despite market contraction in 2023, strategic interest in biologics and advanced therapies remains robust, with a rebound expected by 2025.
Biologics CDMO
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.